In the diabetic milieu—characterized by hyperglycemia, oxidative stress, and accumulation of advanced glycation end-products—SAA amplifies these pathogenic stimuli by enhancing reactive oxygen species generation and promoting endothelial-to-mesenchymal transition [4]. The gene discussed is SAA1; the disease is Hyperglycemia.